tiprankstipranks
Advertisement
Advertisement

GLPG Stock Latest News

Two new option listings and five option delistings on May 8th
The FlyTwo new option listings and five option delistings on May 8th
8d ago
CTRA
EXPI
Galapagos NV Bets Big on Ouro in Earnings Call
PremiumCompany Announcements
Galapagos NV Bets Big on Ouro in Earnings Call
9d ago
GLPG
Galapagos reports Q1 EPS EUR 0.22 vs. EUR (2.33) last year
PremiumThe Fly
Galapagos reports Q1 EPS EUR 0.22 vs. EUR (2.33) last year
10d ago
GLPG
Galapagos Rebrands as Lakefront Biotherapeutics and Reshapes Portfolio Around Gilead–Ouro Autoimmune Deal
PremiumCompany Announcements
Galapagos Rebrands as Lakefront Biotherapeutics and Reshapes Portfolio Around Gilead–Ouro Autoimmune Deal
10d ago
6K
GLPG
GLPG Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
GLPG Earnings Report this Week: Is It a Buy, Ahead of Earnings?
12d ago
GLPG
Galapagos Shareholders Approve Name Change to Lakefront Biotherapeutics and Broad Governance Overhaul
PremiumCompany AnnouncementsGalapagos Shareholders Approve Name Change to Lakefront Biotherapeutics and Broad Governance Overhaul
17d ago
6K
GLPG
Galapagos price target lowered to $28 from $33 at RBC Capital
Premium
The Fly
Galapagos price target lowered to $28 from $33 at RBC Capital
1M ago
GLPG
Galapagos Strikes New Gilead Deal to Co-Develop Gamgertamig and Unlock $500 Million for Strategic Moves
Premium
Company Announcements
Galapagos Strikes New Gilead Deal to Co-Develop Gamgertamig and Unlock $500 Million for Strategic Moves
2M ago
6K
GLPG
Galapagos, Gilead enter pact to collaborate on T cell engager therapies
PremiumThe Fly
Galapagos, Gilead enter pact to collaborate on T cell engager therapies
2M ago
GILD
GLPG
Galapagos Files 2025 Annual Report and Calls April 28 Meetings on Rebranding and Share Buyback
PremiumCompany Announcements
Galapagos Files 2025 Annual Report and Calls April 28 Meetings on Rebranding and Share Buyback
2M ago
6K
GLPG
Galapagos chairman Jerome Contamine to step down, Gino Santini to succeed
PremiumThe Fly
Galapagos chairman Jerome Contamine to step down, Gino Santini to succeed
2M ago
GLPG
Galapagos in partnership discussions with Gilead after Ouro deal
PremiumThe Fly
Galapagos in partnership discussions with Gilead after Ouro deal
2M ago
GILD
GLPG
Galapagos Seeks Strategic Tie-Up With Gilead Around Ouro Medicines Deal and T Cell Engager OM336
PremiumCompany AnnouncementsGalapagos Seeks Strategic Tie-Up With Gilead Around Ouro Medicines Deal and T Cell Engager OM336
2M ago
6K
GLPG
M&A News: Gilead Bets $2B+ on Ouro Medicines to Power Immunology Growth
Premium
Market News
M&A News: Gilead Bets $2B+ on Ouro Medicines to Power Immunology Growth
2M ago
GSK
GILD
Galapagos Discloses Bank of America’s Stake Drop Below 5% Threshold
Premium
Company Announcements
Galapagos Discloses Bank of America’s Stake Drop Below 5% Threshold
2M ago
6K
GLPG
Galapagos Discloses Bank of America Crossing 5% Ownership Threshold in March 2026
PremiumCompany Announcements
Galapagos Discloses Bank of America Crossing 5% Ownership Threshold in March 2026
2M ago
6K
GLPG
Galapagos Launches Major 2026 Subscription Right Plan, Expanding Equity Incentive Pool
PremiumCompany Announcements
Galapagos Launches Major 2026 Subscription Right Plan, Expanding Equity Incentive Pool
2M ago
6K
GLPG
Galapagos Names New Chief HR Officer to Support Ongoing Corporate Transformation
PremiumCompany Announcements
Galapagos Names New Chief HR Officer to Support Ongoing Corporate Transformation
2M ago
6K
GLPG
Galapagos CHRO Annelies Missotten to step down, Tania Philipp to succeed
PremiumThe Fly
Galapagos CHRO Annelies Missotten to step down, Tania Philipp to succeed
2M ago
VOR
GLPG
Galapagos Discloses Bank of America Crossing 5% Shareholding Threshold
PremiumCompany AnnouncementsGalapagos Discloses Bank of America Crossing 5% Shareholding Threshold
2M ago
6K
GLPG
Galapagos NV Earnings Call: Cash Rich, In Transition
Premium
Company Announcements
Galapagos NV Earnings Call: Cash Rich, In Transition
3M ago
GLPG
Galapagos Posts 2025 Profit and Accelerates Strategic Exit from Cell Therapy
Premium
Company Announcements
Galapagos Posts 2025 Profit and Accelerates Strategic Exit from Cell Therapy
3M ago
6K
GLPG

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >